Navigation Links
Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
Date:11/5/2009

SAN DIEGO, Nov. 5, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the 18th Annual Credit Suisse Healthcare Conference in Phoenix, Arizona on Wednesday, November 11, 2009 at 10:00 a.m. PT / 1:00 p.m. ET. Mark Foletta, senior vice president of finance and chief financial officer at Amylin Pharmaceuticals, will be providing a corporate overview.

The audio portion of the presentation will be webcast and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate Web site, located at www.amylin.com. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California. Further information about Amylin Pharmaceuticals is available at www.amylin.com.

SOURCE Amylin Pharmaceuticals, Inc.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Mass. , Feb. 9 Echo ... the needle-free Symphony™ tCGM System as a non-invasive, wireless, ... SkinPrep System for transdermal drug delivery, announced today that ... and CEO, will be interviewed on " Steve Crowley ... 9, 2010 at 9:34 AM ET ...
(Date:2/9/2010)... Feb. 9 Glycemion Strategies, Inc., ... initiatives for diabetic consumers and their professional healthcare ... Retrieval Program to benefit the 30,000 US Diabetes ... clients they serve. ,, The Portrait ... designed to provide real-time access to health information, ...
(Date:2/9/2010)... 9 Takeda Global Research & ... that it has initiated a trial to study ... (PPIs) affect the pharmacokinetics and pharmacodynamics of Plavix ... evaluating all published data and communications from the ... potential risks associated with concomitant use of clopidogrel ...
Breaking Medicine Technology:Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 2Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 3Echo Therapeutics Chairman and CEO to be Interviewed on Steve Crowley's American Scene Radio Program and Featured on Money Channel Inc. 4Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 2Portrait Health(TM) Emergency Medical Data Retrieval Program-Glycemion Strategies Announces Free Membership for Diabetes Educators 3Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate) 2Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate) 3Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate) 4Zymes LLCs Omega 3 Enhanced Water OmegaChill to be Distributed at NFL Alumni Super Bowl XLIV Weekend Events on February 5 7th 2010 11681 1Zymes LLCs Omega 3 Enhanced Water OmegaChill to be Distributed at NFL Alumni Super Bowl XLIV Weekend Events on February 5 7th 2010 11681 2Spherical cows help to dump metabolism law 65790 1Spherical cows help to dump metabolism law 65790 2Spherical cows help to dump metabolism law 65790 3Finland invests 26 23128 3B1 85 million in pan European infrastructure for biomedical research 11680 1Finland invests 26 23128 3B1 85 million in pan European infrastructure for biomedical research 11680 2
... FORT WORTH, Texas, Sept. 30 Wound Care,Innovations, ... (OTC,Bulletin Board: WNDM), announced today that it will ... and Economical Realities in Boston. This,seminar is presented ... Wound Clinic, Podiatry Today and producers of the ...
... ROCKVILLE, Md., Sept. 29 Obese school-age,kids and ... gain if they,participate in medium- to high-intensity behavioral ... by HHS, Agency for Healthcare,Research and Quality., ... studied met for more than 25 hours, usually ...
Other Medicine Technology:Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R) 2Behavioral Modification Programs Help Obese Children Manage Their Weight 2Behavioral Modification Programs Help Obese Children Manage Their Weight 3
(Date:2/9/2010)... Feb. 9 The following ... Rohack , M.D., President, American Medical Association: ... "The American Medical Association is pleased to ... in the Let,s Move Campaign. As the ... worked to address obesity and are committed ...
(Date:2/9/2010)... Cancer Center of University Hospitals (UH) Case Medical Center, ... new standard of care for patients with locally advanced ... of Clinical Cancer Research, the phase one ... well tolerated in combination with standard-of-care cisplatin chemotherapy and ... provided both significant reduction in cancer disease and cancer ...
(Date:2/9/2010)... launched the nation,s first comprehensive research and training ... FBI has called "the crime of the 21st ... to food additives to auto parts- accounts for ... and has a major impact on health and ... Terrorist and other organized crime groups use proceeds ...
(Date:2/9/2010)... WASHINGTON, D.C. (February 9, 2010) AcademyHealth today recognized ... with the 2010 Health Services Research (HSR) Impact ... as a tool to ensure adherence to basic ... award AcademyHealth recognizes research that clearly translated into ... better," said AcademyHealth President W. David Helms, Ph.D. ...
(Date:2/9/2010)... February 8, 2010 An iPhone application created ... of physical activity around the world. Those annual ... use government statistics and a host of indirect ... The information being collected at the University of ... Play iPhone application, available free from Apple,s "App ...
Breaking Medicine News(10 mins):Health News:MSU launches first anti-counterfeiting research program 2Health News:MSU launches first anti-counterfeiting research program 3Health News:2010 HSR Impact Award recognizes surgical safety research 2Health News:Phone app providing real-time statistics on physical activity around the world 2Health News:Phone app providing real-time statistics on physical activity around the world 3
... Ascension Orthopedics, Inc., a,leader in orthopedic extremity implants, ... Warrender, Jr., John F. Walters and David,C. Furr, ... and,experience will make a substantial contribution to the ... on April 14 as Senior Vice President of,Global ...
... Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that it ... its Trofex molecular imaging program for the detection ... is designed to investigate two small molecule radiopharmaceutical ... and MIP-1095, in order to select a lead ...
... 2008: Certain single nucleotide polymorphisms (SNPs) within the interleukin ... be associated with juvenile idiopathic arthritis (JIA), according to ... at EULAR 2008, the Annual Congress of the European ... study, three specific SNPs (small variations in the genetic ...
... serving up a surprise not only for tomato lovers around ... bacterium that causes misery for millions of people. , In ... One , researchers say they,ve identified a molecular trick that ... the University of Rochester Medical Center has identified a protein ...
... Injury Is Key, WASHINGTON, June 13 ... will fly to Germany on Saturday,to work with ... in,assessing their current rehabilitation practices. They will also ... care given to,injured soldiers and other military personnel ...
... Dental Management,Services, Inc. (Nasdaq: BDMS ), operators ... dividend. The Company,s board of directors,has declared a ... of common,stock. The dividend is payable July 11, ... Birner Dental Management Services, Inc. acquires, develops, and ...
Other Medicine News:Health News:Three Industry Veterans Join Ascension Orthopedics 2Health News:Three Industry Veterans Join Ascension Orthopedics 3Health News:Molecular insight begins Trofex Phase 1 trial for detection of metastatic prostate cancer 2Health News:Specific mutations in the IL2RA gene associated with juvenile idiopathic arthritis 2Health News:Salmonella: Trickier than we imagined 2Health News:Salmonella: Trickier than we imagined 3Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 2Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 3Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 4Health News:National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers 5
... This CLS number ... number, created to easily ... If showing no availability ... the old Sigma-Aldrich number ...
Calibrated"to deliver"with blow-out, andpacked in a flip-top canister to keep the pipets racked. Feature: subdivision 0.1 mL volume 5.0 mL...
Corning 7078 Calibrated"to deliver". multi-pack plugged capacity 5 mL...
These reusable 0.1mL PYREX serological pipets are color coded by size for easy identification and sorting. Colored graduations are enameled onto the glass. These "to deliver" (TD) pipets must be blow...
Medicine Products: